Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
IDEAYA Biosciences (IDYA)
NASDAQ:IDYA
IDEAYA Biosciences (IDYA) Stock Price & Analysis
347 Followers
IDYA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.00 - $24.89
Previous Close$24.87
Volume472.60K
Average Volume (3M)705.25K
Market Cap
$1.42B
Enterprise Value$1.09B
Total Cash (Recent Filing)$339.47M
Total Debt (Recent Filing)$3.03M
Price to Earnings (P/E)-16.3
Beta0.18
Next Earnings
Aug 14, 2023EPS Estimate
-$0.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.52
Shares Outstanding57,051,300
10 Day Avg. Volume593,703
30 Day Avg. Volume705,246
Standard Deviation0.24
R-Squared0.04
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)180.06
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue22.94
Enterprise Value/Gross Profit21.37
Enterprise Value/Ebitda-14.68
Forecast
1Y Price Target
$32.70Price Target Upside31.48% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
IDEAYA Biosciences News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IDYA FAQ
What was IDEAYA Biosciences’s price range in the past 12 months?
IDEAYA Biosciences lowest stock price was $9.00 and its highest was $24.89 in the past 12 months.
What is IDEAYA Biosciences’s market cap?
Currently, no data Available
When is IDEAYA Biosciences’s upcoming earnings report date?
IDEAYA Biosciences’s upcoming earnings report date is Aug 14, 2023 which is in 71 days.
How were IDEAYA Biosciences’s earnings last quarter?
IDEAYA Biosciences released its earnings results on May 09, 2023. The company reported -$0.49 earnings per share for the quarter, beating the consensus estimate of -$0.541 by $0.051.
Is IDEAYA Biosciences overvalued?
According to Wall Street analysts IDEAYA Biosciences’s price is currently Undervalued.
Does IDEAYA Biosciences pay dividends?
IDEAYA Biosciences does not currently pay dividends.
What is IDEAYA Biosciences’s EPS estimate?
IDEAYA Biosciences’s EPS estimate is -$0.55.
How many shares outstanding does IDEAYA Biosciences have?
IDEAYA Biosciences has 57,290,176 shares outstanding.
What happened to IDEAYA Biosciences’s price movement after its last earnings report?
IDEAYA Biosciences reported an EPS of -$0.49 in its last earnings report, beating expectations of -$0.541. Following the earnings report the stock price went up 14.624%.
Which hedge fund is a major shareholder of IDEAYA Biosciences?
Among the largest hedge funds holding IDEAYA Biosciences’s share is Deerfield Management Company, LP. It holds IDEAYA Biosciences’s shares valued at 24M.
---
IDEAYA Biosciences Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$32.70 (31.48% Upside)
$32.70 (31.48% Upside)
Blogger Sentiment
Bullish
IDYA Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 830.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $87.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 7.0%
Last 30 Days ▲ 7.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
124.86%
12-Months-Change
Fundamentals
Return on Equity
-21.94%
Trailing 12-Months
Asset Growth
1.64%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
IDEAYA Biosciences
IDEAYA Biosciences, Inc. develops cancer therapeutics. It is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company operates and manages its business as one operating and reportable segment, which is the business of research and development for oncology-focused precision medicine. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.
---
Top 5 ETFs holding IDYA
iShares Biotechnology ETF
$9.00M
iShares Core S&P Total U.S. Stock Market ETF
$870.81K
iShares NASDAQ US Biotechnology UCITS ETF
$655.36K
Fidelity MSCI Health Care Index ETF
$596.52K
iShares Russell 3000 ETF
$227.02K
Up to five ETFs with an Outperform Smart Score that hold IDYA. The ETFs are listed according to market value of IDYA within the ETF
---
---